926 - 950 of 8808 Results
Title
Year
-
OPENTitle: Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials InitiativeJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 4Start Page: 657End Page: 666Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-230363Citation Count: 1
-
OPENTitle: Parkinson’s Disease is Predominantly a Genetic DiseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 3Start Page: 467End Page: 482Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-230376Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd230376?id=journal-of-parkinsons-disease%2Fjpd230376Citation Count: 9
- The Human Affectome2024RESTRICTEDTitle: The Human AffectomeJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 158Issue #:Start Page: 105450End Page: 105450Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.neubiorev.2023.105450Best OA location URL: https://doi.org/10.1016/j.neubiorev.2023.105450Citation Count: 8
-
OPENTitle: Perspectives of People At-Risk on Parkinson’s Prevention ResearchJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 3Start Page: 399End Page: 414Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-230436Citation Count: 5
-
RESTRICTEDTitle: Chaperone-mediated autophagy: machinery, regulation and biological consequencesJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 68Issue #: 5Start Page: 749End Page: 763Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00018-010-0565-6Citation Count: 111
-
RESTRICTEDTitle: Molecular imaging of levodopa-induced dyskinesiasJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 72Issue #: 11Start Page: 2107End Page: 2117Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00018-015-1854-xCitation Count: 17
- Genetic testing in adults with neurologic disorders: indications, approach, and clinical impacts2023RESTRICTEDTitle: Genetic testing in adults with neurologic disorders: indications, approach, and clinical impactsJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 271Issue #: 2Start Page: 733End Page: 747Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-023-12058-6Citation Count: 1
-
RESTRICTEDTitle: Proinflammatory cytokines levels in sepsis and healthy volunteers, and tumor necrosis factor-alpha associated sepsis mortality: A systematic review and meta-analysisJournal Name: CytokinePublisher: Elsevier BVVol: 158Issue #:Start Page: 156006End Page: 156006Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cyto.2022.156006Best OA location URL: https://doi.org/10.1016/j.cyto.2022.156006Citation Count: 25
-
RESTRICTEDTitle: Smaller total and subregional cerebellar volumes in posttraumatic stress disorder: a mega-analysis by the ENIGMA-PGC PTSD workgroupJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 29Issue #: 3Start Page: 611End Page: 623Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41380-023-02352-0Best OA location URL: https://www.nature.com/articles/s41380-023-02352-0.pdfCitation Count: 0
-
RESTRICTEDTitle: The 2022 symposium on dementia and brain aging in low‐ and middle‐income countries: Highlights on research, diagnosis, care, and impactJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.13836Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13836Citation Count: 0
-
RESTRICTEDTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2024 UpdateJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 14Issue #: 5Start Page: 1End Page: 14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-240272Citation Count: 0
-
RESTRICTEDTitle: Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiologyJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 103Issue #:Start Page: 266End Page: 287Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2024.06.016Citation Count: 0
-
RESTRICTEDTitle: BridGE: a pathway-based analysis tool for detecting genetic interactions from GWASJournal Name: Nature ProtocolsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 5Start Page: 1400End Page: 1435Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41596-024-00954-8Citation Count: 0
-
RESTRICTEDTitle: Cognitive dysfunction in animal models of human lewy-body dementiaJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3389/fnagi.2024.1369733Citation Count: 0
-
RESTRICTEDTitle: Inflammation and heterogeneity in synucleinopathiesJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3389/fimmu.2024.1432342Citation Count: 0
-
RESTRICTEDTitle: Synthesis at the Interface of Chemistry and BiologyJournal Name: Accounts of Chemical ResearchPublisher: American Chemical Society (ACS)Vol: 57Issue #: 18Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.accounts.4c00320Citation Count: 0
-
OPENTitle: The immune system in Parkinson’s disease: what we know so farJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awae177Citation Count: 0
-
OPENTitle: Transcriptomics of Human Brain Tissue in Parkinson’s Disease: a Comparison of Bulk and Single-cell RNA SequencingJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 61Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-024-04124-5Citation Count: 2
-
OPENTitle: A framework for translational therapy development in deep brain stimulationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00829-5Citation Count: 0
- The integrated stress response in brain diseases: A double-edged sword for proteostasis and synapses2024OPENTitle: The integrated stress response in brain diseases: A double-edged sword for proteostasis and synapsesJournal Name: Current Opinion in NeurobiologyPublisher: Elsevier BVVol: 87Issue #:Start Page: 102886End Page: 102886Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.conb.2024.102886Citation Count: 1
-
RESTRICTEDTitle: The role of genetics in the treatment of dystonia with deep brain stimulation: Systematic review and Meta-analysisJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 459Issue #:Start Page: 122970End Page: 122970Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2024.122970Citation Count: 0
-
RESTRICTEDTitle: Disease-Modifying Therapies in Parkinson’s DiseaseJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 43Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2024.12.009Citation Count: 0
-
RESTRICTEDTitle: Fanning the Flames in Anti-N-methyl-D-aspartate Receptor EncephalitisJournal Name: International Journal of Gynecological PathologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 34Issue #: 4Start Page: 401End Page: 402Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/pgp.0000000000000186Citation Count: 0
-
OPENTitle: A Spatiotemporal Map of the Aging Mouse Brain Reveals White Matter Tracts as Vulnerable FociJournal Name: SSRN Electronic JournalPublisher: Elsevier BVVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2139/ssrn.4260648Best OA location URL: https://doi.org/10.1101/2022.09.18.508419Citation Count: 2
-
OPENTitle: Sedation and sleep safety of pimavanserin for Parkinsons’s disease psychosis: Review and exploratory analysis of clinical study dataJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 12Issue #:Start Page: 100342End Page: 100342Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100342Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100342Citation Count: 0